75 Biggest Movers From Yesterday

Gainers

• Kodiak Sciences Inc. KOD shares jumped 72.5% to close at $51.05 on Monday after the company reported the sale of future royalties on KSI-301 for $225 million to Baker Bros. Advisors.
• ASLAN Pharmaceuticals Limited ASLN shares rose 36.1% to close at $5.20 after the company reported positive data from its proof-of-concept study of ASLAN004.
• Oramed Pharmaceuticals Inc. ORMP rose 29.7% to close at $5.72 on Monday after climbing 17.91% on Friday.
• Galmed Pharmaceuticals Ltd. GLMD rose 29.3% to close at $5.82.
• NF Energy Saving Corporation BIMI shares climbed 28.9% to close at $3.39 after the company announced it would acquire Chongqing Guanzan Technology for RMB 100 million.
• SAExploration Holdings, Inc. SAEX gained 28.6% to close at $3.06.
• TKK Symphony Acquisition Corporation TKKS climbed 25% to close at $10.20
• Akerna Corp. KERN shares rose 21.5% to close at $9.06.
• China Automotive Systems, Inc. CAAS shares climbed 21.5% to close at $3.85.
• Alimera Sciences, Inc. ALIM rose 20.7% to close at $6.83.
• Jounce Therapeutics, Inc. JNCE shares surged 20.5% to close at $6.52.
• Can-Fite BioPharma Ltd. CANF rose 18.6% to close at $4.20.
• Sorrento Therapeutics, Inc. SRNE shares jumped 17.1% to close at $3.42.
• Hebron Technology Co., Ltd. HEBT rose 16.9% to close at $5.41.
• Iterum Therapeutics plc ITRM surged 16.7% to close at $2.80.
• PDS Biotechnology Corporation PDSB gained 16.2% to close at $2.72.
• IVERIC bio, Inc. ISEE gained 15.5% to close at $3.9050.
• Brainsway Ltd. BWAY rose 15.3% to close at $10.80.
• Yintech Investment Holdings Limited YIN surged 13.4% to close at $5.50 following Q3 results.
• Puma Biotechnology, Inc. PBYI gained 13.1% to close at $10.73. Puma Biotechnology extended its commercialization agreement with Pierre Fabre for NERLYNX to the Middle East, South Africa, Sudan and Turkey.
• Evofem Biosciences Inc EVFM gained 12.3% to close at $6.86 after the company's phase 2b study of Amphora for the prevention of Chlamydia and Gonorrhea met its primary and secondary endpoints.
• Aquestive Therapeutics, Inc. AQST climbed 12.2% to close at $8.74. Aquestive Therapeutics submitted New Drug Application to the FDA for Libervant.
• Ocugen Inc OCGN surged 11.9% to close at $0.4245 after a company director Junge Zhang bought 270,000 shares at an average price of $0.37 per share. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.
• Revance Therapeutics, Inc. RVNC gained 11.9% to close at $20.02. Goldman Sachs initiated coverage on Revance Therapeutics with a Buy rating and a $25 price target.
• trivago N.V. TRVG surged 11.6% to close at $2.60.
• SpringWorks Therapeutics, Inc. SWTX rose 11.6% to close at $25.45.
• Arcadia Biosciences, Inc. RKDA jumped 11.3% to close at $5.53.
• Aravive, Inc. ARAV gained 10.7% to close at $10.65.
• Vir Biotechnology, Inc. VIR climbed 10.5% to close at $13.20.
• Dicerna Pharmaceuticals, Inc. DRNA rose 10.1% to close at $26.48.
• Clovis Oncology, Inc. CLVS rose 10.1% to close at $16.43.
• Solid Biosciences Inc. SLDB shares jumped 9.9% to close at $4.32.
• IDEAYA Biosciences, Inc. IDYA rose 9.8% to close at $8.40.
• Allena Pharmaceuticals, Inc. ALNA surged 9.5% to close at $2.42.
• Axcella Health Inc. AXLA rose 9% to close at $4.36.
• Rekor Systems, Inc. REKR surged 9% to close at $2.67.
• Krystal Biotech, Inc. KRYS shares jumped 8.9% to close at $61.54.
• Novavax, Inc. NVAX gained 7.6% to close at $5.22.
• Afya Limited AFYA shares surged 6.8% to close at $29.41.
• Akari Therapeutics, Plc AKTX rose 4.9% to close at $2.16. Akari Therapeutics announced pivotal Phase III trial design of nomacopan in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA), following the FDA meeting.
• Xenon Pharmaceuticals Inc XENE climbed 4.1% to close at $12.31 after the company received a $50 million upfront payment from Neurocrine Biosciences for the rights to its Xenon's XEN901.